Showing 7021-7030 of 10226 results for "".
- Clearpath Derm Introduces New Digital Pathology Servicehttps://practicaldermatology.com/news/clear-path-derm-introduces-new-digital-pathology-service/2458560/Clearpath Derm has launched Clearpath 3.0, a digital software solution for dermatopathology. Clearpath 3.0 provides dermatologists with real-time access to whole slide images and patient case information from anywhere using a tablet, iPad or computer.
- Untreated Sleep Apnea Linked to Melanoma Aggressionhttps://practicaldermatology.com/news/untreated-sleep-apnea-linked-to-melanoma-aggressiveness/2458564/Untreated severe obstructive sleep apnea (OSA) is linked to increased aggressiveness of malignant cutaneous melanoma, according to research presented at the American Thoracic Society 2016 International Conference in San Francisco. The study involved 412 patients, average age 55.8, w
- Feet Get Skin Cancer Too, ACFAS Warnshttps://practicaldermatology.com/news/feet-get-skin-cancer-too-acfas-warns/2458565/Skin cancer of the foot is prevalent and can be fatal if not caught early, the American College of Foot and Ankle Surgeons (ACFAS) warns. While all types of skin cancer, including squamous cell and basal cell carcinoma, can be found
- Alphaeon Launches PROVOQUE™ Facial Serumhttps://practicaldermatology.com/news/alphaeon-launches-provoque-facial-serum/2458567/Alphaeon Corporation has launched PROVOQUE™ Facial Serum to help address the visible signs of skin aging. PROVOQUE Facial Serum is a stem cell-conditioned media containing growth factors secreted by stem cells.
- Second Skin Gets Second Chancehttps://practicaldermatology.com/news/second-skin-gets-second-chance/2458572/A “second skin” polymer may temporarily protect and tighten skin, and smooth wrinkles. Scientists at MIT, Massachusetts General Hospital, Living Proof, and Olivo Labs developed the material, which could also be used to deliver drugs to help treat skin conditions suc
- New Case Study Highlights Black Henna Tattoo Riskshttps://practicaldermatology.com/news/new-case-study-highlights-black-henna-tattoo-risks/2458573/Black henna tattoos should be avoided, especially during foreign travel, UK doctors warn in BMJ Case Reports. Researchers from the University of Sheffiel
- ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015https://practicaldermatology.com/news/asds-skin-cancer-treatments-among-most-frequently-performed-procedures-in-2015/2458576/Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up 5 percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on
- Global Derm Market Set to Soar Through 2022https://practicaldermatology.com/news/global-derm-market-set-to-soar-through-2022/2458579/The global dermatology market is set to boom from $20 billion in 2015 to $33.7 billion by 2022, representing a compound annual growth rate of 7.7%,
- Sienna Biopharmaceuticals Completes $34 Million Series A Financinghttps://practicaldermatology.com/news/sienna-biopharmaceuticals-completes-34-million-series-a-financing/2458586/Sienna Biopharmaceuticals, Inc., a development stage company focused on aesthetics and medical dermatology, completed a $34 million Series A financing led by ARCH Venture Partners. Additional investors included Altitude Life Science Ventures, Partner Fund Management, and Venvest Capital, as well
- Vitiligo and Gray Hair Treatment Breakthrough? Study IDs Mechanism That Controls Skin and Hair Colorhttps://practicaldermatology.com/news/vitiligo-and-gray-hair-treatment-breakthrough-study-ids-mechanism-that-controls-skin-and-hair-color/2458587/A pair of molecular signals controls skin and hair color in mice and humans - and could be targeted by new drugs to treat skin pigment disorders like vitiligo, according to a report out of NYU Langone Medical Center in New York City. Finding ways to activate these pathways could lea